federal_register: 2018-05659

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts regulation_id_numbers
2018-05659 Drug Products Labeled as Homeopathic; Draft Guidance for Staff and Industry; Availability; Extension of Comment Period Notice The Food and Drug Administration (FDA or Agency) is extending the comment period for the notice entitled "Drug Products Labeled as Homeopathic; Draft Guidance for Food and Drug Administration Staff and Industry; Availability" that appeared in the Federal Register of December 20, 2017. The Agency is taking this action to allow interested persons additional time to submit comments. 2018-03-21 2018 3 https://www.federalregister.gov/documents/2018/03/21/2018-05659/drug-products-labeled-as-homeopathic-draft-guidance-for-staff-and-industry-availability-extension-of https://www.govinfo.gov/content/pkg/FR-2018-03-21/pdf/2018-05659.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA or Agency) is extending the comment period for the notice entitled "Drug Products Labeled as Homeopathic; Draft Guidance for Food and Drug Administration Staff and Industry; Availability" that appeared in the...  

Links from other tables